Scott Kim MD, PhD
Scott Kim, MD, PhD is an
assistant professor in the Department of Psychiatry and a core faculty
member of the Bioethics Program and an investigator at the Center for Behavioral
and Decision Sciences in Medicine at the University of Michigan.
His research focuses on
the ethics of research involving the decisionally
impaired, policy issues in surrogate consent for dementia research, the
ethics of gene transfer research for neurodegenerative disorders, and the
ethics of high risk research, especially as it pertains to special informed
consent concerns such as the therapeutic misconception.
He has used a variety of
research methods, including surveys, decision analyses, qualitative
interviews, and deliberative democratic consultations to address a variety
of bioethics research questions.
His research has been supported by grants from the NIH (NIMH, NINDS,
and NIA), Michael J. Fox Foundation, and the American Association for
Geriatric Psychiatry and the Greenwall Foundation as a Greenwall
Faculty Scholar in Bioethics.
Current and Recent
Research Projects
Ethics
of Surrogate Consent for Dementia Research
(R01 AG029550)
(1R01MH075023-01)
Parkinson's Disease patients'
participation preferences regarding gene transfer therapy studies
NIH Grant U54NS045309 (pipeline project VIII)
Assessing Competence to
Consent in Schizophrenia Research
NIH Grant K23MH064172
Recent articles
Kim
SYH. Assessing and communicating risks
and benefits of gene transfer clinical studies. Current Opinion in Molecular
Therapeutics 2006; 8(5): 384-389.
Srebnik DS, Kim SY. Competency for creation, use, and
revocation of psychiatric advance directives. J Am Acad Psychiatry Law 2006;34(4):501-10
Kim SYH, Appelbaum PS, Swan J,
Stroup TS, McEvoy JP, Goff DC, Jeste DV, Lamberti JS, Leibovici A, and Caine
ED. Determining When Impairment
Constitutes Incapacity for Informed Consent in Schizophrenia Research. British Journal of Psychiatry
2007; 191(1):38-43
Frank S, Wilson R,
Holloway RG, Zimmerman C, Peterson DR, Kieburtz
K, Kim SYH. Ethics of
sham surgery: Perspective of Patients. Movement Disorders 2008; 23(1): 63–68
Karlawish JHT, Kim SYH, Knopman
D, van Dyck CH, James B, and Marson
D. The views of Alzheimer disease
patients and their study partners on proxy consent for clinical trial enrollment. Am J Geriatr
Psychiatry 2008;16(3): 240-247.
Other selected articles
KimCV.pdf
|
